EFFICACY AND SAFETY OF LONG TERM CYCLOPHOSPHAMIDE TREATMENT FOR INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS

被引：2
|
作者：
Kwon, H. M. [1 ]
Karig, E. H. [1 ]
Go, D. J. [1 ]
Park, J. K. [1 ]
Lee, E. Y. [1 ]
Song, Y. W. [1 ]
Lee, H. -J. [2 ]
Lee, E. B. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
[2] Seoul Natl Univ, Coll Med, Radiol, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.4302
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0621
引用
收藏
页码：1011 / 1011
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up
    Tochimoto, Akiko
    Kawaguchi, Yasushi
    Hara, Masako
    Tateishi, Mutsuto
    Fukasawa, Chikako
    Takagi, Kae
    Nishimagi, Emi
    Ota, Yuko
    Katsumata, Yasuhiro
    Gono, Takahisa
    Tanaka, Eiichi
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2011, 21 (03) : 296 - 301
  • [22] LONG-TERM TREATMENT WITH RITUXIMAB IN INTERSTITIAL LUNG DISEASE RELATED TO SYSTEMIC SCLEROSIS: OUR CLINICAL EXPERIENCE
    Lumetti, F.
    Spinella, A.
    Ariani, A.
    Cocchiara, E.
    Colaci, M.
    Silva, M.
    Sverzellati, N.
    Ferri, C.
    Salvarani, C.
    Giuggioli, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 750 - 751
  • [23] Efficacy of the combined therapy with Rituximab plus Cyclophosphamide versus Cyclophosphamide as Monotherapy in Systemic Sclerosis-Associated Interstitial Lung Disease
    Tejeda-Andrade, C. F.
    Villalpando-Gomez, Y.
    Gamez-Nava, J., I
    Castro-Lizano, N.
    Rocha-Munoz, A. D.
    Cardona, Munoz E. G.
    Gonzalez-Lopez, L.
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1193 - 1193
  • [24] PREDICTORS OF RESPONSE AND LONG-TERM EFFICACY AND SAFETY OF NINTEDANIB IN SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE: DATA FROM AN ITALIAN MULTICENTRE STUDY
    Campochiaro, C.
    De Luca, G.
    Lazzaroni, M. G.
    Armentaro, G.
    Ruaro, B.
    Stanziola, A.
    Benfaremo, D.
    De Lorenzis, E.
    Moccaldi, B.
    Bonomi, F.
    Bianchessi, L. M.
    Iannone, F.
    Cacciapaglia, F.
    Spinella, A.
    Guiducci, S.
    Codullo, V.
    Bosello, S. L.
    Cuomo, G.
    Giuggioli, D.
    Dagna, L.
    Matucci-Cerinic, M.
    Zanatta, E.
    Confalonieri, P.
    Del Papa, N.
    Airo, P.
    Moroncini, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [25] CYCLOPHOSPHAMIDE VERSUS MYCOPHENOLATE FOR SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE
    Volkmann, E.
    Tashkin, D.
    Clements, P.
    Roth, M.
    Furst, D.
    Khanna, D.
    Tseng, C-H.
    Arriola, E.
    Elashoff, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 821 - 821
  • [26] Outcome of systemic sclerosis associated interstitial lung disease treated with intravenous cyclophosphamide
    Abhishek, Abhishek
    Yazdani, Ramin
    Pearce, Fiona
    Regan, Marian
    Lim, Ken
    Hubbard, Richard
    Lanyon, Peter
    CLINICAL RHEUMATOLOGY, 2011, 30 (08) : 1099 - 1104
  • [27] Predictors of Response and Long-term Efficacy and Safety of Nintedanib in Systemic Sclerosis-Interstitial Lung Disease: Data from an Italian Multicentre Study
    Campochiaro, Corrado
    De Luca, Giacomo
    Lazzaroni, Maria-Grazia
    Armentaro, Giuseppe
    Spinella, Amelia
    Bellocchi, Chiara
    Ruaro, Barbara
    Stanziola, Anna
    Benfaremo, Devis
    De Lorenzis, Enrico
    Moccaldi, Beatrice
    Bonomi, Francesco
    Bianchessi, Lorenzo
    Iannone, Florenzo
    Cacciapaglia, Fabio
    Beretta, Lorenzo
    Guiducci, Serena
    Codullo, Veronica
    Bosello, Silvia Laura
    Cuomo, Giovanna
    Zanatta, Elisabetta
    Del Papa, Nicoletta
    Airo, Paolo
    Confalonieri, Paola
    Moroncini, Gianluca
    Giuggioli, Dilia
    Dagna, Lorenzo
    Matucci-Cerinic, Marco
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1439 - 1441
  • [28] Outcome of systemic sclerosis associated interstitial lung disease treated with intravenous cyclophosphamide
    Abhishek Abhishek
    Ramin Yazdani
    Fiona Pearce
    Marian Regan
    Ken Lim
    Richard Hubbard
    Peter Lanyon
    Clinical Rheumatology, 2011, 30
  • [29] Analysis of patients with interstitial lung disease associated to Systemic Sclerosis treated with cyclophosphamide
    Arreguy Nogueira, Luiz Paulo
    Mancuzo, Eliane
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [30] THE EFFECT OF CYCLOPHOSPHAMIDE ON LUNG FUNCTION IN DIFFERENT STAGES OF INTERSTITIAL LUNG DISEASE ASSOCIATED TO SYSTEMIC SCLEROSIS
    Van Den Hombergh, W. M. T.
    Teesselink, E.
    Knaapen-Hans, H. K. A.
    Simons, S. O.
    van den Hoogen, F. H. J.
    Fransen, J.
    Vonk, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 526 - 526
12345